deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02801942

Immune Profile in Subjects With New Onset Type 1 Diabetes

Exploration of the Peripheral Immune System in Subjects With New Onset T1 Diabetes (NOT1D)

Sponsor: GlaxoSmithKline

Conditions Diabetes Mellitus, Type 1
Interventions Inguinal lymph node core biopsy Inguinal lymph node fine needle aspirate biopsy Peripheral blood collection Pre- and post-biopsy questionnaire
Updated 14 times since 2017 Last updated: Oct 4, 2018 Started: Jul 25, 2016 Primary completion: Dec 21, 2017 Completion: Dec 21, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02801942, this NA trial focuses on Diabetes Mellitus, Type 1 and remains completed. Sponsored by GlaxoSmithKline, it has been updated 14 times since 2016, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~May 2017 · 4 months · monthly snapshot~May 2017 – ~Oct 2017 · 5 months · monthly snapshot~Oct 2017 – ~Feb 2018 · 4 months · monthly snapshot~Feb 2018 – ~Jun 2018 · 4 months · monthly snapshot~Jun 2018 – ~Sep 2018 · 3 months · monthly snapshot~Sep 2018 – ~Mar 2019 · 6 months · monthly snapshot~Mar 2019 – ~Jan 2021 · 22 months · monthly snapshot~Jan 2021 – ~Jan 2022 · 12 months · monthly snapshot~Jan 2022 – ~Mar 2022 · 59 days · monthly snapshot~Mar 2022 – ~Dec 2022 · 9 months · monthly snapshot~Dec 2022 – ~Jan 2023 · 31 days · monthly snapshot~Jan 2023 – ~Jul 2024 · 18 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

14 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Jan 2023 — Jul 2024 [monthly]

    Completed NA

  4. Dec 2022 — Jan 2023 [monthly]

    Completed NA

  5. Mar 2022 — Dec 2022 [monthly]

    Completed NA

▶ Show 9 earlier versions

  1. Jan 2022 — Mar 2022 [monthly]

    Completed NA

  2. Jan 2021 — Jan 2022 [monthly]

    Completed NA

  3. Mar 2019 — Jan 2021 [monthly]

    Completed NA

  4. Sep 2018 — Mar 2019 [monthly]

    Completed NA

  5. Jun 2018 — Sep 2018 [monthly]

    Completed NA

  6. Feb 2018 — Jun 2018 [monthly]

    Completed NA

    Status: Recruiting → Completed

  7. Oct 2017 — Feb 2018 [monthly]

    Recruiting NA

  8. May 2017 — Oct 2017 [monthly]

    Recruiting NA

  9. Jan 2017 — May 2017 [monthly]

    Recruiting NA

    First recorded

Jul 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • GlaxoSmithKline
Data source: GlaxoSmithKline

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations